EVs derived from a human chronic myeloid leukemia (CML) cell line (LAMA84) enhanced tumor growth both in vitro and in vivo by providing antiapoptotic molecules and TGF-β (38). Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.